Ligand Pharmaceuticals, Inc. (LGND)
199.93
+0.31
(+0.16%)
USD |
NASDAQ |
Apr 02, 16:00
199.59
-0.34
(-0.17%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap : 3.987B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.533B |
| ADMA Biologics, Inc. | 2.210B |
| Intuitive Surgical, Inc. | 156.27B |
| Globus Medical, Inc. | 11.91B |
| Establishment Labs Holdings, Inc. | 1.700B |
Market Cap Related Metrics
| PE Ratio | 34.27 |
| PS Ratio | 15.08 |
| Price to Book Value | 3.919 |
| Price to Free Cash Flow | 106.26 |
| Price | 199.93 |
| Earnings Yield | 2.92% |
| Operating PE Ratio | 85.65 |
| Normalized PE Ratio | 64.80 |